Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 9 |
GO:0005737 | cytoplasm | 2 | 10 |
GO:0043226 | organelle | 2 | 10 |
GO:0043227 | membrane-bounded organelle | 3 | 9 |
GO:0043229 | intracellular organelle | 3 | 10 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A0A3Q8IFP3
Term | Name | Level | Count |
---|---|---|---|
GO:0000154 | rRNA modification | 6 | 11 |
GO:0001510 | RNA methylation | 4 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006364 | rRNA processing | 8 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009451 | RNA modification | 5 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0016072 | rRNA metabolic process | 7 | 11 |
GO:0031167 | rRNA methylation | 5 | 11 |
GO:0032259 | methylation | 2 | 11 |
GO:0034470 | ncRNA processing | 7 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034660 | ncRNA metabolic process | 6 | 11 |
GO:0036265 | RNA (guanine-N7)-methylation | 5 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0043414 | macromolecule methylation | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0070475 | rRNA base methylation | 6 | 11 |
GO:0070476 | rRNA (guanine-N7)-methylation | 6 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0008168 | methyltransferase activity | 4 | 11 |
GO:0008173 | RNA methyltransferase activity | 4 | 11 |
GO:0008649 | rRNA methyltransferase activity | 5 | 11 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 11 |
GO:0016435 | rRNA (guanine) methyltransferase activity | 6 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 11 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 11 |
GO:0140102 | catalytic activity, acting on a rRNA | 4 | 11 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 322 | 326 | PF00656 | 0.664 |
CLV_C14_Caspase3-7 | 412 | 416 | PF00656 | 0.476 |
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.492 |
CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.342 |
CLV_NRD_NRD_1 | 246 | 248 | PF00675 | 0.354 |
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.454 |
CLV_NRD_NRD_1 | 356 | 358 | PF00675 | 0.712 |
CLV_NRD_NRD_1 | 384 | 386 | PF00675 | 0.231 |
CLV_NRD_NRD_1 | 407 | 409 | PF00675 | 0.234 |
CLV_NRD_NRD_1 | 422 | 424 | PF00675 | 0.252 |
CLV_PCSK_FUR_1 | 405 | 409 | PF00082 | 0.291 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.339 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.354 |
CLV_PCSK_KEX2_1 | 358 | 360 | PF00082 | 0.648 |
CLV_PCSK_KEX2_1 | 371 | 373 | PF00082 | 0.536 |
CLV_PCSK_KEX2_1 | 382 | 384 | PF00082 | 0.227 |
CLV_PCSK_KEX2_1 | 405 | 407 | PF00082 | 0.229 |
CLV_PCSK_KEX2_1 | 421 | 423 | PF00082 | 0.229 |
CLV_PCSK_PC1ET2_1 | 358 | 360 | PF00082 | 0.648 |
CLV_PCSK_PC1ET2_1 | 371 | 373 | PF00082 | 0.536 |
CLV_PCSK_PC1ET2_1 | 382 | 384 | PF00082 | 0.227 |
CLV_PCSK_SKI1_1 | 247 | 251 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.333 |
CLV_PCSK_SKI1_1 | 389 | 393 | PF00082 | 0.242 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.431 |
DOC_MAPK_gen_1 | 288 | 296 | PF00069 | 0.329 |
DOC_MAPK_gen_1 | 29 | 39 | PF00069 | 0.449 |
DOC_PP2B_LxvP_1 | 45 | 48 | PF13499 | 0.415 |
DOC_PP4_FxxP_1 | 305 | 308 | PF00568 | 0.429 |
DOC_USP7_MATH_1 | 111 | 115 | PF00917 | 0.490 |
DOC_USP7_MATH_1 | 373 | 377 | PF00917 | 0.687 |
DOC_USP7_UBL2_3 | 382 | 386 | PF12436 | 0.426 |
LIG_14-3-3_CanoR_1 | 22 | 27 | PF00244 | 0.384 |
LIG_14-3-3_CanoR_1 | 408 | 418 | PF00244 | 0.525 |
LIG_Actin_WH2_2 | 230 | 248 | PF00022 | 0.367 |
LIG_Actin_WH2_2 | 81 | 98 | PF00022 | 0.480 |
LIG_EVH1_2 | 11 | 15 | PF00568 | 0.473 |
LIG_FHA_1 | 130 | 136 | PF00498 | 0.601 |
LIG_FHA_1 | 310 | 316 | PF00498 | 0.603 |
LIG_FHA_2 | 139 | 145 | PF00498 | 0.546 |
LIG_FHA_2 | 410 | 416 | PF00498 | 0.429 |
LIG_LIR_Gen_1 | 240 | 249 | PF02991 | 0.357 |
LIG_LIR_Gen_1 | 394 | 404 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 102 | 108 | PF02991 | 0.611 |
LIG_LIR_Nem_3 | 240 | 245 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 394 | 400 | PF02991 | 0.429 |
LIG_PCNA_PIPBox_1 | 231 | 240 | PF02747 | 0.327 |
LIG_PCNA_yPIPBox_3 | 225 | 238 | PF02747 | 0.351 |
LIG_SH2_CRK | 242 | 246 | PF00017 | 0.308 |
LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.353 |
LIG_SH2_STAT5 | 293 | 296 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 418 | 421 | PF00017 | 0.429 |
LIG_SH3_3 | 196 | 202 | PF00018 | 0.344 |
LIG_SH3_3 | 254 | 260 | PF00018 | 0.476 |
LIG_SH3_3 | 278 | 284 | PF00018 | 0.343 |
LIG_SUMO_SIM_anti_2 | 213 | 218 | PF11976 | 0.420 |
LIG_SUMO_SIM_par_1 | 63 | 69 | PF11976 | 0.512 |
LIG_TYR_ITIM | 103 | 108 | PF00017 | 0.456 |
LIG_UBA3_1 | 44 | 49 | PF00899 | 0.510 |
LIG_UBA3_1 | 94 | 99 | PF00899 | 0.372 |
MOD_CK1_1 | 416 | 422 | PF00069 | 0.426 |
MOD_CK1_1 | 71 | 77 | PF00069 | 0.333 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.673 |
MOD_CK2_1 | 255 | 261 | PF00069 | 0.440 |
MOD_Cter_Amidation | 369 | 372 | PF01082 | 0.540 |
MOD_GlcNHglycan | 113 | 116 | PF01048 | 0.467 |
MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.564 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.554 |
MOD_GlcNHglycan | 184 | 187 | PF01048 | 0.623 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.415 |
MOD_GlcNHglycan | 337 | 340 | PF01048 | 0.596 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.458 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.455 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.376 |
MOD_GSK3_1 | 321 | 328 | PF00069 | 0.744 |
MOD_GSK3_1 | 409 | 416 | PF00069 | 0.429 |
MOD_N-GLC_1 | 16 | 21 | PF02516 | 0.390 |
MOD_N-GLC_1 | 58 | 63 | PF02516 | 0.540 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.663 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.491 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.472 |
MOD_NEK2_1 | 237 | 242 | PF00069 | 0.386 |
MOD_PKA_1 | 22 | 28 | PF00069 | 0.500 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.384 |
MOD_PKA_2 | 373 | 379 | PF00069 | 0.734 |
MOD_PKB_1 | 372 | 380 | PF00069 | 0.669 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.725 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.460 |
MOD_Plk_1 | 58 | 64 | PF00069 | 0.525 |
MOD_Plk_2-3 | 147 | 153 | PF00069 | 0.696 |
MOD_Plk_2-3 | 321 | 327 | PF00069 | 0.621 |
MOD_Plk_4 | 237 | 243 | PF00069 | 0.353 |
MOD_SUMO_for_1 | 400 | 403 | PF00179 | 0.485 |
TRG_ENDOCYTIC_2 | 105 | 108 | PF00928 | 0.589 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.302 |
TRG_ENDOCYTIC_2 | 292 | 295 | PF00928 | 0.315 |
TRG_ER_diArg_1 | 22 | 24 | PF00400 | 0.414 |
TRG_ER_diArg_1 | 232 | 234 | PF00400 | 0.337 |
TRG_ER_diArg_1 | 245 | 247 | PF00400 | 0.334 |
TRG_ER_diArg_1 | 357 | 360 | PF00400 | 0.624 |
TRG_ER_diArg_1 | 383 | 385 | PF00400 | 0.456 |
TRG_ER_diArg_1 | 405 | 408 | PF00400 | 0.485 |
TRG_ER_diArg_1 | 420 | 423 | PF00400 | 0.380 |
TRG_NLS_Bipartite_1 | 357 | 375 | PF00514 | 0.646 |
TRG_NLS_Bipartite_1 | 405 | 427 | PF00514 | 0.442 |
TRG_NLS_MonoCore_2 | 381 | 386 | PF00514 | 0.427 |
TRG_NLS_MonoCore_2 | 422 | 427 | PF00514 | 0.621 |
TRG_NLS_MonoExtC_3 | 356 | 361 | PF00514 | 0.636 |
TRG_NLS_MonoExtC_3 | 381 | 386 | PF00514 | 0.427 |
TRG_NLS_MonoExtN_4 | 354 | 361 | PF00514 | 0.686 |
TRG_NLS_MonoExtN_4 | 421 | 427 | PF00514 | 0.442 |
TRG_PTS1 | 424 | 427 | PF00515 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PC68 | Leptomonas seymouri | 72% | 100% |
A0A1X0P9R3 | Trypanosomatidae | 52% | 100% |
A0A3R7KRG3 | Trypanosoma rangeli | 52% | 100% |
A4HAZ1 | Leishmania braziliensis | 80% | 99% |
A4IA51 | Leishmania infantum | 100% | 100% |
C9ZM51 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 100% |
E9B565 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4Q2S0 | Leishmania major | 93% | 100% |
V5B593 | Trypanosoma cruzi | 52% | 100% |